{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:24:30Z","timestamp":1773674670517,"version":"3.50.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Women Scientist scheme, department of science and technology, New Delhi","award":["WOS-A\/LS-684\/2016"],"award-info":[{"award-number":["WOS-A\/LS-684\/2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12094-022-02833-8","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T06:03:41Z","timestamp":1654149821000},"page":"1702-1714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The road-map for establishment of a prognostic molecular marker panel in glioma using liquid biopsy: current status and future directions"],"prefix":"10.1007","volume":"24","author":[{"given":"Richa","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-5207","authenticated-orcid":false,"given":"Puneet","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragini","family":"Gothalwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"2833_CR1","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","volume":"4","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol. 2018;4:1254\u201362. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1789.","journal-title":"JAMA Oncol."},{"key":"2833_CR2","doi-asserted-by":"publisher","unstructured":"Fernandes C, Costa A, Os\u00f3rio L, et al. Current Standards of Care in Glioblastoma Therapy. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017. Chapter11. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK469987\/https:\/\/doi.org\/10.15586\/codon.glioblastoma.2017.ch11","DOI":"10.15586\/codon.glioblastoma.2017.ch11"},{"key":"2833_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-015-1798-x","volume":"123","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu S, Fan X, Li S, Wang R, Wang L, Ma J, Jiang T, Ma W. Age-associated brain regions in gliomas: a volumetric analysis. J Neurooncol. 2015;123:299\u2013306. https:\/\/doi.org\/10.1007\/s11060-015-1798-x.","journal-title":"J Neurooncol."},{"key":"2833_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12885-016-2131-6]","volume":"16","author":"C Jungk","year":"2016","unstructured":"Jungk C, Chatziaslanidou D, Ahmadi R, Capper D, Bermejo JL, Exner J, von Deimling A, Herold-Mende C, Unterberg A. Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-na\u00efve patients. BMC Cancer. 2016;16:81. https:\/\/doi.org\/10.1186\/s12885-016-2131-6].","journal-title":"BMC Cancer."},{"key":"2833_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fphar.2018.00879]","volume":"9","author":"E Alphand\u00e9ry","year":"2018","unstructured":"Alphand\u00e9ry E. Glioblastoma treatments: an account of recent industrial developments. Front Pharmacol. 2018;9:879. https:\/\/doi.org\/10.3389\/fphar.2018.00879].","journal-title":"Front Pharmacol."},{"key":"2833_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12885-017-3909-x]","volume":"1","author":"L Xia","year":"2018","unstructured":"Xia L, Fang C, Chen G, Sun C. Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis. BMC Cancer. 2018;1:48. https:\/\/doi.org\/10.1186\/s12885-017-3909-x].","journal-title":"BMC Cancer."},{"key":"2833_CR7","doi-asserted-by":"publisher","unstructured":"Liang J, Lv X, Lu C, Ye X, Chen X, Fu J, Luo C, Zhao Y. Prognostic factors of patients with Gliomas \u2013 an analysis on 335 patients with Glioblastoma and other forms of Gliomas. BMC Cancer. 2020; 20:35 https:\/\/doi.org\/10.1186\/s12885-019-6511-6","DOI":"10.1186\/s12885-019-6511-6"},{"key":"2833_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/annonc\/mdu050","volume":"25","author":"R Stupp","year":"2014","unstructured":"Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G. ESMO guidelines working group. high-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:93\u2013101. https:\/\/doi.org\/10.1093\/annonc\/mdu050.","journal-title":"Ann Oncol."},{"key":"2833_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13014-016-0702-y]","volume":"11","author":"L Guo","year":"2016","unstructured":"Guo L, Wang G, Feng Y, Yu T, Guo Y, Bai X, Ye Z. Diffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumors. Radiat Oncol. 2016;11:123. https:\/\/doi.org\/10.1186\/s13014-016-0702-y].","journal-title":"Radiat Oncol."},{"key":"2833_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13244-020-00888-1]","volume":"11","author":"V Sawlani","year":"2020","unstructured":"Sawlani V, Patel MD, Davies N, Flintham R, Wesolowski R, Ughratdar I, Pohl U, Nagaraju S, Petrik V, Kay A, Jacob S, Sanghera P, Wykes V, Watts C, Poptani H. Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesions. Insights Imaging. 2020;11:84. https:\/\/doi.org\/10.1186\/s13244-020-00888-1].","journal-title":"Insights Imaging."},{"key":"2833_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803\u201320. https:\/\/doi.org\/10.1007\/s00401-016-1545-1.","journal-title":"Acta Neuropathol."},{"key":"2833_CR12","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1038\/d41586-018-06711-8]","volume":"561","author":"S DeWeerdt","year":"2018","unstructured":"DeWeerdt S. The genomics of brain cancer. Nature. 2018;561:S54\u20135. https:\/\/doi.org\/10.1038\/d41586-018-06711-8].","journal-title":"Nature."},{"key":"2833_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11864-018-0559-4]","volume":"19","author":"LA Ramkissoon","year":"2018","unstructured":"Ramkissoon LA, Britt N, Guevara A, Whitt E, Severson E, Sathyan P, Gay L, Elvin J, Ross JS, Brown C, Stogner-Underwood K, Mott R, Kram D, Strowd R, Lesser GJ, Ramkissoon SH. Precision neuro-oncology: the role of genomic testing in the management of adult and pediatric gliomas. Curr Treat Options Oncol. 2018;19:41. https:\/\/doi.org\/10.1007\/s11864-018-0559-4].","journal-title":"Curr Treat Options Oncol."},{"key":"2833_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11060-015-1829-7","volume":"124","author":"A Kiviniemi","year":"2015","unstructured":"Kiviniemi A, Gardberg M, Frantz\u00e9n J, Parkkola R, Vuorinen V, Pesola M, Minn H. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival. J Neurooncol. 2015;124:237\u201345. https:\/\/doi.org\/10.1007\/s11060-015-1829-7.","journal-title":"J Neurooncol."},{"key":"2833_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3171\/2016.11.JNS161187","volume":"128","author":"SV Manda","year":"2018","unstructured":"Manda SV, Kataria Y, Tatireddy BR, Ramakrishnan B, Ratnam BG, Lath R, Ranjan A, Ray A. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas. J Neurosurg. 2018;128:1091\u2013101. https:\/\/doi.org\/10.3171\/2016.11.JNS161187.","journal-title":"J Neurosurg."},{"key":"2833_CR16","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2015.1.FOCUS14755.]","volume":"38","author":"M Karsy","year":"2015","unstructured":"Karsy M, Neil JA, Guan J, Mahan MA, Colman H, Jensen RL. A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus. 2015;38:E4. https:\/\/doi.org\/10.3171\/2015.1.FOCUS14755.].","journal-title":"Neurosurg Focus."},{"key":"2833_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/cells8080863]","volume":"8","author":"AS Silantyev","year":"2019","unstructured":"Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics. Cells. 2019;8:863. https:\/\/doi.org\/10.3390\/cells8080863].","journal-title":"Cells."},{"key":"2833_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3171\/2017.3.JNS162280]","volume":"129","author":"JM Figueroa","year":"2018","unstructured":"Figueroa JM, Carter BS. Detection of glioblastoma in biofluids. J Neurosurg. 2018;129:334\u201340. https:\/\/doi.org\/10.3171\/2017.3.JNS162280].","journal-title":"J Neurosurg."},{"key":"2833_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40291-020-00449-8]","volume":"24","author":"D Chen","year":"2020","unstructured":"Chen D, Xu T, Wang S, Chang H, Yu T, Zhu Y, Chen J. Correction to: liquid biopsy applications in the clinic. Mol Diagn Ther. 2020;24:125\u201333. https:\/\/doi.org\/10.1007\/s40291-020-00449-8].","journal-title":"Mol Diagn Ther."},{"key":"2833_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025.","journal-title":"Immunity"},{"key":"2833_CR21","doi-asserted-by":"publisher","first-page":"1779990","DOI":"10.1080\/2162402X.2020.1779990]","volume":"9","author":"E Marinari","year":"2020","unstructured":"Marinari E, Allard M, Gustave R, Widmer V, Philippin G, Merkler D, Tsantoulis P, Dutoit V, Dietrich PY. Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma. Oncoimmunology. 2020;9:1779990. https:\/\/doi.org\/10.1080\/2162402X.2020.1779990].","journal-title":"Oncoimmunology."},{"key":"2833_CR22","doi-asserted-by":"publisher","unstructured":"Aguilar-Cazares D, Chavez-Dominguez R, Carlos-Reyes A, Lopez-Camarillo C, Hernadez de la Cruz ON, Lopez-Gonzalez JS. Contribution of Angiogenesis to Inflammation and Cancer. Front Oncol. 2019; 9: 1399. https:\/\/doi.org\/10.3389\/fonc.2019.01399","DOI":"10.3389\/fonc.2019.01399"},{"key":"2833_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 2010;40:294\u2013309. https:\/\/doi.org\/10.1016\/j.molcel.2010.09.022.","journal-title":"Mol Cell."},{"key":"2833_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nri2607]","volume":"9","author":"V Nizet","year":"2009","unstructured":"Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol. 2009;9:609\u201317. https:\/\/doi.org\/10.1038\/nri2607].","journal-title":"Nat. Rev. Immunol."},{"key":"2833_CR25","doi-asserted-by":"publisher","first-page":"914104","DOI":"10.1155\/2013\/914104]","volume":"2013","author":"H Konnecke","year":"2013","unstructured":"Konnecke H, Bechmann I. The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol. 2013;2013:914104. https:\/\/doi.org\/10.1155\/2013\/914104].","journal-title":"Clin Dev Immunol."},{"key":"2833_CR26","doi-asserted-by":"publisher","unstructured":"Armento A, Ehlers J, Sch\u00f6tterl S, Naumann U. Molecular Mechanisms of Glioma Cell Motility. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017. Chapter 5. [https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470001\/https:\/\/doi.org\/10.15586\/codon.glioblastoma.2017.ch5","DOI":"10.15586\/codon.glioblastoma.2017.ch5"},{"key":"2833_CR27","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.3892\/ol.2018.9227","volume":"16","author":"AJ West","year":"2018","unstructured":"West AJ, Tsui V, Stylli SS, Nguyen HP, Morokoff AP, Kaye AH, Luwor RB. The role of interleukin 6 STAT3 signalling in glioblastoma (Review). Oncol Lett. 2018;16:4095\u2013104. https:\/\/doi.org\/10.3892\/ol.2018.9227.","journal-title":"Oncol Lett"},{"key":"2833_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/2347-8659.139717","volume":"1","author":"ET Ha","year":"2014","unstructured":"Ha ET, Antonios JP, Soto H, Prins RM, Yang I, Kasahara N, Liau LM, Kruse CA. Chronic inflammation drives glioma growth: cellular and molecular factors responsible for an immunosuppressive microenvironment. NeuroimmunolNeuroinflamm. 2014;1:66\u201376. https:\/\/doi.org\/10.4103\/2347-8659.139717.","journal-title":"NeuroimmunolNeuroinflamm"},{"key":"2833_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.it.2014.12.008.]","volume":"36","author":"J Mauer","year":"2015","unstructured":"Mauer J, Denson JL, Br\u00fcning JC. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol. 2015;36:92\u2013101. https:\/\/doi.org\/10.1016\/j.it.2014.12.008.].","journal-title":"Trends Immunol."},{"key":"2833_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fimmu.2016.00604]","volume":"7","author":"Y Luo","year":"2016","unstructured":"Luo Y, Zheng SG. Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms. Front Immunol. 2016;7:604. https:\/\/doi.org\/10.3389\/fimmu.2016.00604].","journal-title":"Front Immunol."},{"key":"2833_CR31","first-page":"9114","volume":"8","author":"Y Shan","year":"2015","unstructured":"Shan Y, He X, Song W, Han D, Niu J, Wang J. Role of IL-6 in the invasiveness and prognosis of glioma. Int J Clin Exp Med. 2015;8:9114\u201320.","journal-title":"Int J Clin Exp Med"},{"key":"2833_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7150\/jca.16415","volume":"8","author":"Z Li","year":"2017","unstructured":"Li Z, Huang Q, Chen H, Lin Z, Zhao M, Jiang Z. Interferon regulatory factor 7 promoted glioblastoma progression and stemness by modulating IL-6 expression in microglia. J Cancer. 2017;8:207\u201319. https:\/\/doi.org\/10.7150\/jca.16415.","journal-title":"J Cancer."},{"key":"2833_CR33","doi-asserted-by":"publisher","unstructured":"Gandhi P, Khare R, Garg N, Sorte S. Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival. World J Clin Cases. 2017; 5: 247\u2013253. https:\/\/doi.org\/10.12998\/wjcc.v5.i6.247","DOI":"10.12998\/wjcc.v5.i6.247"},{"key":"2833_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11060-018-2803-y]","volume":"138","author":"A Bunevicius","year":"2018","unstructured":"Bunevicius A, Radziunas A, Tamasauskas S, Tamasauskas A, Laws ER, Iervasi G, Bunevicius R, Deltuva V. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients. J Neurooncol. 2018;138:351\u20138. https:\/\/doi.org\/10.1007\/s11060-018-2803-y].","journal-title":"J Neurooncol."},{"key":"2833_CR35","doi-asserted-by":"publisher","first-page":"979748","DOI":"10.1155\/2013\/979748","volume":"2013","author":"R Albulescu","year":"2013","unstructured":"Albulescu R, Codrici E, Popescu ID, Mihai S, Necula LG, Petrescu D, Teodoru M, Tanase CP. Cytokine patterns in brain tumour progression. Mediators Inflamm. 2013;2013:979748. https:\/\/doi.org\/10.1155\/2013\/979748.","journal-title":"Mediators Inflamm."},{"key":"2833_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137524","volume":"10","author":"MB Nijaguna","year":"2015","unstructured":"Nijaguna MB, Patil V, Hegde AS, Chandramouli BA, Arivazhagan A, Santosh V, Somasundaram K. An eighteen serum cytokine signature for discriminating glioma from normal healthy individuals. PLoS One. 2015;10: e0137524. https:\/\/doi.org\/10.1371\/journal.pone.0137524.","journal-title":"PLoS One."},{"key":"2833_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3906\/sag-1611-77]","volume":"48","author":"CD Deniz","year":"2018","unstructured":"Deniz CD, G\u00fcrbilek M, Ko\u00e7 M. Prognostic value of interferon-gamma, interleukin-6, and tumor necrosis factor-alpha in the radiation response of patients diagnosed with locally advanced non-small-cell lung cancer and glioblastoma multiforme. Turk J Med Sci. 2018;48:117\u201323. https:\/\/doi.org\/10.3906\/sag-1611-77].","journal-title":"Turk J Med Sci."},{"key":"2833_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ebiom.2018.06.014]","volume":"33","author":"L Zhenjiang","year":"2018","unstructured":"Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, J\u00e4ger E, Peredo IH, Dodoo E, Maeurer M. Cytokine networks and survivin peptide-specific cellular immune responses predict improved survival in patients with glioblastoma multiforme. EBioMedicine. 2018;33:49\u201356. https:\/\/doi.org\/10.1016\/j.ebiom.2018.06.014].","journal-title":"EBioMedicine."},{"key":"2833_CR39","doi-asserted-by":"publisher","unstructured":"Shamsdin SA, Mehrafshan A, Rakei SM, Mehrabani D. Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran. Asian Pac J Cancer Prev. 2019; 20: 2883\u20132890. https:\/\/doi.org\/10.31557\/APJCP.2019.20.10.2883","DOI":"10.31557\/APJCP.2019.20.10.2883"},{"key":"2833_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112945]","volume":"9","author":"S Adams","year":"2014","unstructured":"Adams S, Teo C, McDonald KL, Zinger A, Bustamante S, Lim CK, Sundaram G, Braidy N, Brew BJ, Guillemin GJ. Involvement of the kynurenine pathway in human glioma pathophysiology. PLoS One. 2014;9: e112945. https:\/\/doi.org\/10.1371\/journal.pone.0112945].","journal-title":"PLoS One."},{"key":"2833_CR41","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jocn.2015.06.018","volume":"22","author":"L Zhai","year":"2015","unstructured":"Zhai L, Dey M, Lauing KL, Gritsina G, Kaur R, Lukas RV, Nicholas MK, Rademaker AW, Dostal CR, McCusker RH, Raizer JJ, Parsa AT, Bloch O, Wainwright DA. The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy. J Clin Neurosci. 2015;22:1964\u20138. https:\/\/doi.org\/10.1016\/j.jocn.2015.06.018.","journal-title":"J Clin Neurosci."},{"key":"2833_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4172\/2471-9552.1000125","volume":"2","author":"A Lenzen","year":"2016","unstructured":"Lenzen A, Zhai L, Lauing KL, Gritsina G, Ladomersky E, Genet M, James CD, Bloch O, Wainwright DA. The Kynurenine\/tryptophan ratio and glioblastoma patients treated with hsppc-96 vaccine. Immunotherapy (Los Angel). 2016;2:125. https:\/\/doi.org\/10.4172\/2471-9552.1000125.","journal-title":"Immunotherapy (Los Angel)."},{"key":"2833_CR43","doi-asserted-by":"crossref","unstructured":"Gandhi P, Shrivastava R, Garg N, Sorte SK. Novel molecular panel for evaluating systemic inflammation and survival in therapy na\u00efve glioma patients. World J Clin Oncol 2021; 12(10): 0\u20130","DOI":"10.5306\/wjco.v12.i10.947"},{"key":"2833_CR44","doi-asserted-by":"publisher","unstructured":"El-Badawy A, Ghoneim NI, Nasr MA, Elkhenany H, Ahmed TA, Ahmed SM, El-Badri N. Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells. Biol Open. 2018;7: bio034181. https:\/\/doi.org\/10.1242\/bio.034181","DOI":"10.1242\/bio.034181"},{"key":"2833_CR45","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/ncb2621]","volume":"14","author":"A Ghosh","year":"2012","unstructured":"Ghosh A, Saginc G, Leow SC, Khattar E, Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, Zhou J, Chng WJ, Li S, Liu E, Tergaonkar V. Telomerase directly regulates NF-\u03baB-dependent transcription. Nat Cell Biol. 2012;14:1270\u201381. https:\/\/doi.org\/10.1038\/ncb2621].","journal-title":"Nat Cell Biol."},{"key":"2833_CR46","doi-asserted-by":"publisher","first-page":"30813","DOI":"10.1074\/jbc.M115.681619","volume":"290","author":"R Chen","year":"2015","unstructured":"Chen R, Zhang K, Chen H, Zhao X, Wang J, Li L, Cong Y, Ju Z, Xu D, Williams BR, Jia J, Liu JP. Telomerase deficiency causes alveolar stem cell senescence-associated low-grade inflammation in lungs. J Biol Chem. 2015;290:30813\u201329. https:\/\/doi.org\/10.1074\/jbc.M115.681619.","journal-title":"J Biol Chem."},{"key":"2833_CR47","doi-asserted-by":"publisher","first-page":"8084","DOI":"10.1093\/nar\/gkz584","volume":"47","author":"H Liu","year":"2019","unstructured":"Liu H, Yang Y, Ge Y, Liu J, Zhao Y. TERC promotes cellular inflammatory response independent of telomerase. Nucleic Acids Res. 2019;47:8084\u201395. https:\/\/doi.org\/10.1093\/nar\/gkz584.","journal-title":"Nucleic Acids Res."},{"key":"2833_CR48","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/bjc.2014.538","volume":"111","author":"M Labussi\u00e8re","year":"2014","unstructured":"Labussi\u00e8re M, Di Stefano AL, Gleize V, Boisselier B, Giry M, Mangesius S, Bruno A, Paterra R, Marie Y, Rahimian A, Finocchiaro G, Houlston RS, Hoang-Xuan K, Idbaih A, Delattre JY, Mokhtari K, Sanson M. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. Br J Cancer. 2014;111:2024\u201332. https:\/\/doi.org\/10.1038\/bjc.2014.538.","journal-title":"Br J Cancer."},{"key":"2833_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11060-017-2578-6","volume":"135","author":"P Gandhi","year":"2017","unstructured":"Gandhi P, Khare R, Garg N. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker? J Neurooncol. 2017;135:255\u201361. https:\/\/doi.org\/10.1007\/s11060-017-2578-6.","journal-title":"J Neurooncol."},{"key":"2833_CR50","doi-asserted-by":"publisher","unstructured":"Gandhi P, Khare R, Garg N, Sorte Sk. Interlinked expression of tumor attributes: Can their evaluation serve as a noninvasive paradigm for prognosis in glioblastoma? Int J Neurooncol. 2020; 3:32\u20137. https:\/\/doi.org\/10.4103\/IJNO.IJNO_22_19","DOI":"10.4103\/IJNO.IJNO_22_19"},{"key":"2833_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1158\/1078-0432.CCR-20-3083","volume":"27","author":"K Muralidharan","year":"2021","unstructured":"Muralidharan K, Yekula A, Small JL, Rosh ZS, Kang KM, Wang L, Lau S, Zhang H, Lee H, Bettegowda C, Chicoine MR, Kalkanis SN, Shankar GM, Nahed BV, Curry WT, Jones PS, Cahill DP, Balaj L, Carter BS. TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas. Clin Cancer Res. 2021;27:169\u201378. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3083.","journal-title":"Clin Cancer Res."},{"key":"2833_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/biomedicines5030036","volume":"5","author":"OA Akinrinmade","year":"2017","unstructured":"Akinrinmade OA, Jordaan S, Hristodorov D, Mladenov R, Mungra N, Chetty S, Barth S. Human MAP Tau based targeted cytolytic fusion proteins. Biomedicines. 2017;5:36. https:\/\/doi.org\/10.3390\/biomedicines5030036.","journal-title":"Biomedicines."},{"key":"2833_CR53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fnagi.2019.00231","volume":"11","author":"R Gargini","year":"2019","unstructured":"Gargini R, Segura-Collar B, S\u00e1nchez-G\u00f3mez P. Novel functions of the neurodegenerative-related gene Tau in cancer. Front Aging Neurosci. 2019;11:231. https:\/\/doi.org\/10.3389\/fnagi.2019.00231.","journal-title":"Front Aging Neurosci"},{"key":"2833_CR54","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3892\/or.2018.6896","volume":"41","author":"S Zaman","year":"2019","unstructured":"Zaman S, Chobrutskiy BI, Sikaria D, Blanck G. MAPT (Tau) expression is a biomarker for an increased rate of survival for low grade glioma. Oncol Rep. 2019;41:1359\u201366. https:\/\/doi.org\/10.3892\/or.2018.6896.","journal-title":"Oncol Rep"},{"key":"2833_CR55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12885-019-5287-z","volume":"19","author":"A Darlix","year":"2019","unstructured":"Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, De Forges H, Firmin N, Guiu S, Jacot W, Lehmann S. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases. BMC Cancer. 2019;19:110. https:\/\/doi.org\/10.1186\/s12885-019-5287-z.","journal-title":"BMC Cancer."},{"key":"2833_CR56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1586\/ern.13.42","volume":"13","author":"AU Ahmed","year":"2013","unstructured":"Ahmed AU, Auffinger B, Lesniak MS. Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies. Expert Rev Neurother. 2013;13:545\u201355. https:\/\/doi.org\/10.1586\/ern.13.42.","journal-title":"Expert Rev Neurother."},{"key":"2833_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-14366-4_1","volume":"1139","author":"DV Brown","year":"2019","unstructured":"Brown DV, Stylli SS, Kaye AH, Mantamadiotis T. Multilayered heterogeneity of glioblastoma stem cells: biological and clinical significance. Adv Exp Med Biol. 2019;1139:1\u201321. https:\/\/doi.org\/10.1007\/978-3-030-14366-4_1.","journal-title":"Adv Exp Med Biol."},{"key":"2833_CR58","doi-asserted-by":"publisher","first-page":"7849890","DOI":"10.1155\/2016\/7849890]","volume":"2016","author":"BD Liebelt","year":"2016","unstructured":"Liebelt BD, Shingu T, Zhou X, Ren J, Shin SA, Hu J. Glioma stem cells: signaling, microenvironment, and therapy. Stem Cells Int. 2016;2016:7849890. https:\/\/doi.org\/10.1155\/2016\/7849890].","journal-title":"Stem Cells Int."},{"key":"2833_CR59","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ccr.2009.12.049","volume":"17","author":"R Chen","year":"2010","unstructured":"Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, Lamszus K, Westphal M, Heim S, James CD, VandenBerg SR, Costello JF, Moorefield S, Cowdrey CJ, Prados M, Phillips HS. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010;17:362\u201375. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.049.","journal-title":"Cancer Cell."},{"key":"2833_CR60","first-page":"159","volume":"17","author":"P Mahzouni","year":"2012","unstructured":"Mahzouni P, Jafari M. The study of CD117 expression in glial tumors and its relationship with the tumor-type and grade. J Res Med Sci. 2012;17:159\u201363.","journal-title":"J Res Med Sci"},{"key":"2833_CR61","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/1873-3468.13084","volume":"592","author":"R Hannen","year":"2018","unstructured":"Hannen R, Bartsch JW. Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis. FEBS Lett. 2018;592:2023\u201331. https:\/\/doi.org\/10.1002\/1873-3468.13084.","journal-title":"FEBS Lett."},{"key":"2833_CR62","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.3390\/ijms20235950","volume":"20","author":"O Mendez","year":"2019","unstructured":"Mendez O, P\u00e9rez J, Soberino J, Racca F, Cort\u00e9s J, Villanueva J. Clinical implications of extracellular HMGA1 in breast cancer. Int J Mol Sci. 2019;20:5950. https:\/\/doi.org\/10.3390\/ijms20235950.","journal-title":"Int J Mol Sci."},{"key":"2833_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2011.01.105","volume":"1384","author":"H Fan","year":"2011","unstructured":"Fan H, Guo H, Zhang IY, Liu B, Luan L, Xu S, Hou X, Liu W, Zhang R, Wang X, Pang Q. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251. Brain Res. 2011;1384:9\u201314. https:\/\/doi.org\/10.1016\/j.brainres.2011.01.105.","journal-title":"Brain Res."},{"key":"2833_CR64","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1089\/ars.2008.2400","volume":"11","author":"KM Oliver","year":"2009","unstructured":"Oliver KM, Garvey JF, Ng CT, Veale DJ, Fearon U, Cummins EP, Taylor CT. Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. Antioxid Redox Signal. 2009;11:2057\u201364. https:\/\/doi.org\/10.1089\/ars.2008.2400.","journal-title":"Antioxid Redox Signal."},{"key":"2833_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","volume":"7","author":"V Petrova","year":"2018","unstructured":"Petrova V, Annicchiarico-Petruzzelli M, Melino G, Amelio I. The hypoxic tumour microenvironment. Oncogenesis. 2018;7:10. https:\/\/doi.org\/10.1038\/s41389-017-0011-9.","journal-title":"Oncogenesis."},{"key":"2833_CR66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cell.2011.06.006","volume":"146","author":"CE Eyler","year":"2011","unstructured":"Eyler CE, Wu Q, Yan K, MacSwords JM, Chandler-Militello D, Misuraca KL, Lathia JD, Forrester MT, Lee J, Stamler JS, Goldman SA, Bredel M, McLendon RE, Sloan AE, Hjelmeland AB, Rich JN. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell. 2011;146:53\u201366. https:\/\/doi.org\/10.1016\/j.cell.2011.06.006.","journal-title":"Cell."},{"key":"2833_CR67","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393\u2013410. https:\/\/doi.org\/10.1038\/nrc3064.","journal-title":"Nat Rev Cancer."},{"key":"2833_CR68","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3892\/ol.2016.4952]","volume":"12","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Chen WW, Zhang X. Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches. Oncol Lett. 2016;12:2283\u20138. https:\/\/doi.org\/10.3892\/ol.2016.4952].","journal-title":"Oncol Lett."},{"key":"2833_CR69","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/neuonc\/now258","volume":"19","author":"N Colwell","year":"2017","unstructured":"Colwell N, Larion M, Giles AJ, Seldomridge AN, Sizdahkhani S, Gilbert MR, Park DM. Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol. 2017;19:887\u201396. https:\/\/doi.org\/10.1093\/neuonc\/now258.","journal-title":"Neuro Oncol."},{"key":"2833_CR70","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.3390\/ijms20225794","volume":"20","author":"RP Iglesia","year":"2019","unstructured":"Iglesia RP, Fernandes CFL, Coelho BP, Prado MB, Melo Escobar MI, Almeida GHDR, Lopes MH. Heat shock proteins in glioblastoma biology: where do we stand? Int J Mol Sci. 2019;20:5794. https:\/\/doi.org\/10.3390\/ijms20225794.","journal-title":"Int J Mol Sci."},{"key":"2833_CR71","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4172\/2155-9899.1000264","volume":"5","author":"S Breuninger","year":"2014","unstructured":"Breuninger S, Erl J, Knape C, Gunther S, Regel I, Rodel F, Gaip US, Thorsteinsdottir J, Giannitrapani L, Dickinson AM, Multhoff G. Quantitative analysis of liposomal heat shock protein 70 (Hsp70) in the blood of tumor patients using a novel lipHsp70 Elisa. J Clin Cell Immunol. 2014;5:264. https:\/\/doi.org\/10.4172\/2155-9899.1000264.","journal-title":"J Clin Cell Immunol"},{"key":"2833_CR72","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11060-017-2600-z","volume":"135","author":"J Thorsteinsdottir","year":"2017","unstructured":"Thorsteinsdottir J, Stangl S, Fu P, Guo K, Albrecht V, Eigenbrod S, Erl J, Gehrmann M, Tonn JC, Multhoff G, Schichor C. Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas. J Neurooncol. 2017;135:443\u201352. https:\/\/doi.org\/10.1007\/s11060-017-2600-z.","journal-title":"J Neurooncol."},{"key":"2833_CR73","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3109\/09553002.2014.916841","volume":"90","author":"C Peitzsch","year":"2014","unstructured":"Peitzsch C, Perrin R, Hill RP, Dubrovska A, Kurth I. Hypoxia as a biomarker for radioresistant cancer stem cells. Int J Radiat Biol. 2014;90:636\u201352. https:\/\/doi.org\/10.3109\/09553002.2014.916841.","journal-title":"Int J Radiat Biol."},{"key":"2833_CR74","doi-asserted-by":"publisher","first-page":"6809105","DOI":"10.1155\/2016\/6809105","volume":"2016","author":"A Fidoamore","year":"2016","unstructured":"Fidoamore A, Cristiano L, Antonosante A, d\u2019Angelo M, Di Giacomo E, Astarita C, Giordano A, Ippoliti R, Benedetti E, Cimini A. Glioblastoma stem cells microenvironment: the paracrine roles of the niche in drug and radioresistance. Stem Cells Int. 2016;2016:6809105. https:\/\/doi.org\/10.1155\/2016\/6809105.","journal-title":"Stem Cells Int."},{"key":"2833_CR75","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","volume":"57","author":"BK Ahir","year":"2020","unstructured":"Ahir BK, Engelhard HH, Lakka SS. Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol Neurobiol. 2020;57:2461\u201378. https:\/\/doi.org\/10.1007\/s12035-020-01892-8.","journal-title":"Mol Neurobiol."},{"key":"2833_CR76","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4161\/cam.3.2.7910","volume":"3","author":"T Wurdinger","year":"2009","unstructured":"Wurdinger T, Tannous BA. Glioma angiogenesis: Towards novel RNA therapeutics. Cell Adh Migr. 2009;3:230\u20135. https:\/\/doi.org\/10.4161\/cam.3.2.7910.","journal-title":"Cell Adh Migr."},{"key":"2833_CR77","doi-asserted-by":"publisher","first-page":"1359479","DOI":"10.1080\/20013078.2017.1359479","volume":"6","author":"L Treps","year":"2017","unstructured":"Treps L, Perret R, Edmond S, Ricard D, Gavard J. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles. J Extracell Vesicles. 2017;6:1359479. https:\/\/doi.org\/10.1080\/20013078.2017.1359479.","journal-title":"J Extracell Vesicles."},{"key":"2833_CR78","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3892\/ol.2017.6221","volume":"14","author":"H Xu","year":"2017","unstructured":"Xu H, Zong H, Ma C, Ming X, Shang M, Li K, He X, Du H, Cao L. Epidermal growth factor receptor in glioblastoma. Oncol Lett. 2017;14:512\u20136. https:\/\/doi.org\/10.3892\/ol.2017.6221.","journal-title":"Oncol Lett."},{"key":"2833_CR79","doi-asserted-by":"publisher","unstructured":"Saadeh FS, Mahfouz R, Assi HI. EGFR as a clinical marker in glioblastomas and other gliomas. Int J Biol Markers. 2018; 33: 22\u201332 https:\/\/doi.org\/10.5301\/ijbm.5000301","DOI":"10.5301\/ijbm.5000301"},{"key":"2833_CR80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/030089160709300308","volume":"93","author":"M Quaranta","year":"2007","unstructured":"Quaranta M, Divella R, Daniele A, Di Tardo S, Venneri MT, Lolli I, Troccoli G. Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas. Tumori. 2007;93:275\u201380.","journal-title":"Tumori"},{"key":"2833_CR81","doi-asserted-by":"publisher","unstructured":"Bienkowski M, Piaskowski S, Stoczy\u0144ska-Fidelus E, Szybka M, Banaszczyk M, Witusik-Perkowska M, Jesie\u0144-Lewandowicz E, Jask\u00f3lski DJ, Radomiak-Za\u0142uska A, Jesionek-Kupnicka D, Sikorska B, Papierz W, Rieske P, Liberski PP. Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients. PLoS One. 2013; 8: e65444. https:\/\/doi.org\/10.1371\/journal.pone.0065444","DOI":"10.1371\/journal.pone.0065444"},{"key":"2833_CR82","doi-asserted-by":"publisher","first-page":"11065","DOI":"10.1007\/s13277-015-4742-y","volume":"37","author":"F Spath","year":"2016","unstructured":"Spath F, Andersson U, Dahlin AM, Langseth H, Hovig E, Johannesen TB, Grankvist K, Bj\u00f6rkblom B, Wibom C, Melin B. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study. Tumour Biol. 2016;37:11065\u201372. https:\/\/doi.org\/10.1007\/s13277-015-4742-y.","journal-title":"Tumour Biol."},{"key":"2833_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/417413","author":"Xu Chengshi","year":"2013","unstructured":"Chengshi Xu, Xing Wu, Zhu J. VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2. Scient World J. 2013. https:\/\/doi.org\/10.1155\/2013\/417413.","journal-title":"Scient World J"},{"key":"2833_CR84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-017-0721-9","volume":"16","author":"S Setrerrahmane","year":"2017","unstructured":"Setrerrahmane S, Xu H. Tumor-related interleukins: old validated targets for new anti-cancer drug development. Mol Cancer. 2017;16:153. https:\/\/doi.org\/10.1186\/s12943-017-0721-9.","journal-title":"Mol Cancer."},{"key":"2833_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3171\/2009.5.JNS081074","volume":"112","author":"N Rafat","year":"2010","unstructured":"Rafat N, Beck GCh, Schulte J, Tuettenberg J, Vajkoczy P. Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg. 2010;112:43\u20139. https:\/\/doi.org\/10.3171\/2009.5.JNS081074.","journal-title":"J Neurosurg."},{"key":"2833_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192395","volume":"13","author":"A Nowacka","year":"2018","unstructured":"Nowacka A, Smuczy\u0144ski W, Ro\u015b\u0107 D, Wo\u017aniak-D\u0105browska K, \u015aniegocki M. Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors. PLoS One. 2018;13: e0192395. https:\/\/doi.org\/10.1371\/journal.pone.0192395.","journal-title":"PLoS One."},{"key":"2833_CR87","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/revneuro-2020-0062","volume":"32","author":"H Seyedmirzaei","year":"2020","unstructured":"Seyedmirzaei H, Shobeiri P, Turgut M, Hanaei S, Rezaei N. VEGF levels in patients with glioma: a systematic review and meta-analysis. Rev Neurosci. 2020;32:191\u2013202. https:\/\/doi.org\/10.1515\/revneuro-2020-0062.","journal-title":"Rev Neurosci."},{"key":"2833_CR88","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/cancers14010238","volume":"14","author":"NV Popova","year":"2022","unstructured":"Popova NV, Jucker M. The functional role of extracellular matrix proteins in cancer. Cancers. 2022;14:238. https:\/\/doi.org\/10.3390\/cancers14010238.","journal-title":"Cancers"},{"key":"2833_CR89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/MNM.S105123","volume":"5","author":"NA Pullen","year":"2018","unstructured":"Pullen NA, Pickford AR, Perry MM, Jaworski DM, Loveson KF, Arthur DJ, Holliday JR, Van Meter TE, Peckham R, Younas W, Briggs SEJ, MacDonald S, Butterfield T, Constantinou M, Fillmore HL. Current insights into matrix metalloproteinases and glioma progression: transcending the degradation boundary. Metalloprotein Med. 2018;5:13\u201330. https:\/\/doi.org\/10.2147\/MNM.S105123.","journal-title":"Metalloprotein Med"},{"key":"2833_CR90","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/13102818.2019.1626282","volume":"33","author":"I Dimitrova","year":"2019","unstructured":"Dimitrova I, Tacheva T, Mindo I, Petrov B, Aleksandrova E, Valkanov S, Gulubova M, Vlaykova T. Serum levels of MMP-7 in primary brain cancers and brain metastases. Biotechnol Equip. 2019;33:881\u20135. https:\/\/doi.org\/10.1080\/13102818.2019.1626282.","journal-title":"Biotechnol Equip"},{"key":"2833_CR91","doi-asserted-by":"publisher","unstructured":"Bonan S, Albrengues J, Grasset E, Kuzet SE, Nottet N, Bourget I, Bertero T, Mari B, Meneguzzi G, Gaggioli C. Membrane-bound ICAM-1 contributes to the onset of proinvasivetumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts. Oncotarget. 2017; 8: 1304\u20131320. https:\/\/doi.org\/10.18632\/oncotarget.13610","DOI":"10.18632\/oncotarget.13610"},{"key":"2833_CR92","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0304-3835(99)00255-4","volume":"146","author":"A Salmaggi","year":"1999","unstructured":"Salmaggi A, Eoli M, Frigerio S, Ciusani E, Silvani A, Boiardi A. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients. Cancer Lett. 1999;146:169\u201372. https:\/\/doi.org\/10.1016\/s0304-3835(99)00255-4.","journal-title":"Cancer Lett."},{"key":"2833_CR93","unstructured":"Nano R, Capelli E, Argentina F, Facoetti A, Gerzeli G. Evaluation of serum levels of cytokines and intercellular adhesion molecule-1 (ICAM-1) in astrocytic tumours. Cellular and Molecular Biology (Noisy-le-Grand, France). 2003; 49: 525\u2013528"},{"key":"2833_CR94","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10238-009-0040-6","volume":"9","author":"RV Burim","year":"2009","unstructured":"Burim RV, Teixeira SA, Colli BO, Peria FM, Tirapelli LF, Marie SK, Malheiros SM, Oba-Shinjo SM, Gabbai AA, Lotufo PA, Carlotti-J\u00fanior CG. ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. Clin Exp Med. 2009;9:157\u201363. https:\/\/doi.org\/10.1007\/s10238-009-0040-6.","journal-title":"Clin Exp Med."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-02833-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:43:53Z","timestamp":1659113033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-02833-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":94,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2833"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-02833-8","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"NA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}